Saran Saund - 03 Sep 2021 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
Chief Business Officer
Signature
/s/ Saran Saund
Issuer symbol
OTLC
Transactions as of
03 Sep 2021
Net transactions value
$0
Form type
4
Filing time
08 Sep 2021, 17:00:37 UTC
Previous filing
16 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLC Stock Options Award $0 +675,000 $0.000000 675,000 03 Sep 2021 Common Stock 675,000 $0.1393 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Options vest as follows: (i) 50% of the options will vest upon the consummation of a qualifying joint venture agreement, licensing agreement, or acquisition transaction (a "Corporate Transaction"); (ii) The remaining 50% on the one-year anniversary of the consummation of a Corporate Transaction.